Company intelligence / Profile preview

Quantum Pharmaceutical

Burnopfield, Co Durham, UKquantumpharmaceutical.co.uk ↗

Ownership: Private
Employees: ~99
Development stage: Commercial

Overview

Quantum Pharmaceutical is the UK's leading manufacturer and supplier of unlicensed medicines ("specials") and hard-to-source pharmaceutical products. It provides bespoke formulations in response to prescriber requests, serving retail pharmacies, wholesalers, hospitals, homecare providers, and care homes. The business is fully licensed by the MHRA and adheres to GMP/GDP standards. It was acquired by Clinigen Group in 2017 for £150.3 million; later acquired by Target Healthcare in 2021.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Not specifically listed post-acquisition; previously partnered with Lloyds Development Capital during management buyout phase.

Beyond the preview

Go deeper on Quantum Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quantum Pharmaceutical.

Explore the full profile